Afibrinogenemia is a rare inherited disorder characterized by the absence or severe deficiency of fibrinogen, a protein necessary for blood clotting. The International Classification of Diseases, 10th Revision (ICD-10) provides a specific code for this condition, which is D68.0. This code falls under Chapter III: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.
On the other hand, the International Classification of Diseases, 9th Revision (ICD-9) was used prior to the implementation of ICD-10. The corresponding code for afibrinogenemia in ICD-9 is 286.3. This code is found under Chapter 5: Diseases and Disorders of the Circulatory System.
It is important to note that ICD codes are used for various purposes, including medical billing, research, and tracking health statistics. These codes allow healthcare professionals to accurately document and classify diseases, facilitating communication and understanding among healthcare providers.
Afibrinogenemia is a serious condition that can lead to excessive bleeding, both spontaneously and following injury or surgery. The absence or severe deficiency of fibrinogen prevents the formation of stable blood clots, which can result in prolonged bleeding and potentially life-threatening complications.
Treatment for afibrinogenemia typically involves replacing the missing fibrinogen through infusion of cryoprecipitate or fibrinogen concentrates. Close monitoring and appropriate management of bleeding episodes are crucial to prevent complications and ensure optimal patient outcomes.
Please consult with a healthcare professional or medical coder for any specific coding or diagnostic inquiries, as they can provide the most up-to-date and accurate information regarding ICD codes.
Author: DiseaseMaps Editorial Team
Reviewed against authoritative medical sources (NIH GARD, Orphanet, OMIM)
Last updated: 2023-07-10
Medical disclaimer:
This information does not substitute professional medical advice. Always consult your doctor before making health decisions.